Catalyst Pharmaceutical Inc. (CPRX) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for CPRX. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 19,158,785 | $602M | INCREASED |
| State Street | 7,627,036 | $240M | INCREASED |
| Boston Partners | 1,658,936 | $52M | DECREASED |
| Swedbank AB | 775,032 | $24M | INCREASED |
| BNY Mellon | 703,228 | $22M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Michael Wayne Kalb (Chief Financial Officer) | SELL | 39,701 | 2026-07-15 | |
| Michael Wayne Kalb (Chief Financial Officer) | SELL | 13,788 | 2026-07-15 | |
| Michael Wayne Kalb (Chief Financial Officer) | SELL | 21,416 | 2026-07-15 | |
| Michael Wayne Kalb (Chief Financial Officer) | SELL | 131,536 | $3M | 2026-07-15 |
| Michael Wayne Kalb (Chief Financial Officer) | SELL | 169,248 | $4M | 2026-07-15 |
Full institutional holdings, insider history, and congressional trades for Catalyst Pharmaceutical Inc. on SentiSense.